ArticleBMC cancer2025

Evaluation of intraductal carcinoma and invasive cribriform carcinoma as predictors of genetic mutations in systemic treatment-naïve prostate cancer patients.

Sangmin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.